The lawsuit also statements that Because the onset with the stimulant lack, FDA regulatory officers reached out to Ascent in September 2022 and July and August of 2023, each time "request[ing] no matter if Ascent experienced any offer of your merchandise offered.The payment we get from advertisers isn't going to impact the recommendations or guidan